cardiovascular disease burden
Sep 05, 2025
Key Cardiovascular Deals of 2025: Sealing the Heartbeat
The cardiovascular space has witnessed a surge in strategic collaborations and licensing deals as companies race to address the rising global burden of heart disease with next-generation therapies. Recent transactions reflect a sharpened focus on precision cardiology, novel protein targets, and RNA-based approaches...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
